Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Laubach

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|May 30, 2019
Initial Therapy in Older Patients with Multiple MyelomaJacob Laubach
Nature Reviews. Clinical Oncology|December 24, 2010
Hematology: Bortezomib and dexamethasone induction for multiple myelomaJacob Laubach, Paul Richardson
Cancer Treatment and Research|October 4, 2016
Management of Transplant-Eligible Patients with Newly Diagnosed Multiple MyelomaJacob Laubach, Shaji Kumar
The Oncologist|October 17, 2008
Current and emerging strategies for the management of acute myeloid leukemia in the elderlyJacob Laubach, Arati V Rao
Annual Review of Medicine|November 25, 2010
Multiple myelomaJacob Laubach, Paul Richardson, Kenneth Anderson
Nature Reviews. Clinical Oncology|March 23, 2011
Hematology: Setting the standard for newly diagnosed multiple myelomaJacob Laubach, Paul G Richardson, Kenneth Anderson
The New England Journal of Medicine|September 27, 2018
A Sticky SituationRahul Vedula, Anand Vaidya, Kristin Galetta, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Seminars in Oncology|October 19, 2013
Clinical translation in multiple myeloma: from bench to bedsideJacob Laubach, Teru Hideshima, Paul Richardson, et al.
Expert Opinion on Biological Therapy|October 25, 2013
Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Jacob Laubach, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|May 30, 2019
Initial Therapy in Older Patients with Multiple MyelomaJacob Laubach
Nature Reviews. Clinical Oncology|December 24, 2010
Hematology: Bortezomib and dexamethasone induction for multiple myelomaJacob Laubach, Paul Richardson
Cancer Treatment and Research|October 4, 2016
Management of Transplant-Eligible Patients with Newly Diagnosed Multiple MyelomaJacob Laubach, Shaji Kumar
The Oncologist|October 17, 2008
Current and emerging strategies for the management of acute myeloid leukemia in the elderlyJacob Laubach, Arati V Rao
Annual Review of Medicine|November 25, 2010
Multiple myelomaJacob Laubach, Paul Richardson, Kenneth Anderson
Nature Reviews. Clinical Oncology|March 23, 2011
Hematology: Setting the standard for newly diagnosed multiple myelomaJacob Laubach, Paul G Richardson, Kenneth Anderson
The New England Journal of Medicine|September 27, 2018
A Sticky SituationRahul Vedula, Anand Vaidya, Kristin Galetta, et al.
Oncology (Williston Park, N.Y.)|May 30, 2009
Maximizing the clinical benefit of novel therapies in multiple myelomaJacob Laubach, Constantine Mitsiades, Kenneth Anderson, et al.
Seminars in Oncology|October 19, 2013
Clinical translation in multiple myeloma: from bench to bedsideJacob Laubach, Teru Hideshima, Paul Richardson, et al.
Expert Opinion on Biological Therapy|October 25, 2013
Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Jacob Laubach, et al.
Pageof 9